Anzeige
Mehr »
Dienstag, 02.06.2026 - Börsentäglich über 12.000 News
Entsteht hier die nächste Quantum-Story?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 898123 | ISIN: US9418481035 | Ticker-Symbol: WAZ
Tradegate
01.06.26 | 20:08
322,20 Euro
-0,86 % -2,80
Branche
Sonstige Technologie
Aktienmarkt
S&P 500
1-Jahres-Chart
WATERS CORPORATION Chart 1 Jahr
5-Tage-Chart
WATERS CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
321,20326,0010:26
322,20326,6001.06.

Aktuelle News zur WATERS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoWolfe Research initiates Waters stock with Outperform rating2
MoWolfe Research stuft Waters-Aktie mit "Outperform" ein3
WATERS Aktie jetzt für 0€ handeln
MoWaters Corporation: Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research194Delivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper biological insight for next-generation multiomics, therapeutic, and high-throughput workflows.Identifies...
► Artikel lesen
MoWaters Corporation: Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics179>10x step-change in MS/MS sensitivity paired with multipass Cyclic Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of...
► Artikel lesen
22.05.WATERS CORP /DE/ - 8-K, Current Report10
18.05.Waters Corporation to Present at the Jefferies Global Healthcare Conference352MILFORD, Mass., May 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat...
► Artikel lesen
05.05.Waters forecasts 2026 adjusted EPS of $14.40 to $14.60 as it raises organic growth outlook to 6.5% to 8%7
05.05.Waters hebt Prognose an und übertrifft Erwartungen - Aktie legt kräftig zu26
05.05.Waters Q1 2026 slides: acquisition drives revenue surge, synergies ahead4
05.05.Waters Aktie: Übernahme-Skeptiker stumm geschaltet - Mega-Beat!16
05.05.Waters Q1 Revenue Surges On Acquisitions, Expects Q2 Sales To Jump; Ups Annual Adj. Profit Outlook337WASHINGTON (dpa-AFX) - Waters Corporation (WAT), a provider of analytical instruments, diagnostics technologies, scientific software, and others, on Tuesday posted a net loss for the first quarter....
► Artikel lesen
05.05.Waters (WAT) Beats Q1 Earnings and Revenue Estimates6
05.05.Waters beats top-line and bottom-line estimates; introduces Q2 and raises FY26 outlook6
05.05.Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results535First Quarter 2026 HighlightsTotal reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and...
► Artikel lesen
05.05.WATERS CORP /DE/ - 8-K, Current Report1
04.05.Waters vor dem Quartalsbericht: Integration von BD im Fokus der Anleger4
20.04.Waters Corporation Schedules First Quarter 2026 Earnings Conference Call431MILFORD, Mass., April 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2026 financial results conference call on Tuesday, May 5, 2026 at 8:30 a.m. Eastern Time. A live...
► Artikel lesen
15.04.Waters Corporation's Q1 2026 Earnings: What to Expect15
15.04.Waters Corporation: Waters Announces CE Mark for Next-Generation Fully Automated BD BACTEC FXI Culture System for Bloodstream Infection Diagnosis501Achieves a ~3-hour faster time to detection (~15% reduction) versus the prior generation system, per clinical study data,¹ enabling earlier targeted therapy.First-of-its-kind blood volume...
► Artikel lesen
14.04.Waters Corporation: Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules365Delivers up to 4x faster chromatographic run times to accelerate decisions across discovery, development, and quality workflows.1,3Achieves 10x improvement in absolute molar mass and extended...
► Artikel lesen
Weiter >>
104 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1